Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Blood (2025) 146 (Supplement 1): 7066.

https://doi.org/10.1182/blood-2025-7066

Published: 2025

Journal Articles

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

Blood (2025) 146 (Supplement 1): 7055.

https://doi.org/10.1182/blood-2025-7055

Published: 2025

Journal Articles

Germline predisposition in hematologic malignancies: A study of 22 cases with germline DNA

Gabriela Barbosa, Rodrigo Kojima, Luiz Gustavo Cortes, Renata Minillo, Paulo Campregher, Renata Kishimoto, Mauren dos Santos, Luiz Frederico Honorato, Fabio Santos, Nelson Hamerschlak, Elvira Velloso

Blood (2025) 146 (Supplement 1): 6748.

https://doi.org/10.1182/blood-2025-6748

Published: 2025

Journal Articles

The brazilian registry of hematopoietic cell transplantation and cellular therapy: A MODEL of collaborative progress and DATA management leadership

Cinthya Da Silva, Anderson Simione, Afonso Vigorito, Nelson Hamerschlak, Carmem Bonfim, Mary Flowers, Adriana Seber, Antonio de Macedo, Heliz Neves, Marcelo Pasquini, Fernando Barroso Duarte

Blood (2025) 146 (Supplement 1): 8212.

https://doi.org/10.1182/blood-2025-8212

Published: 2025

Journal Articles

DATA structuring and performance indicators for decision making in oncology and hematology

Bruno Pina, Edson Dias, Cinthya Da Silva, Graziely De Oliveira, Gustavo Rezende, Daniel Almeida, Nelson Hamerschlak, Vanessa Teich

Blood (2025) 146 (Supplement 1): 8209.

https://doi.org/10.1182/blood-2025-8209

Published: 2025

Journal Articles

Real-world outcomes of teclistamab in triple-exposed relapsed/refractory multiple myeloma: Brazilian single-center experience

Mariana Kerbauy, Danielle Ovigli, Newton Centuriao, Lucila Kerbauy, Ricardo Helman, Guilherme Perini, Fabio Santos, Andreza Ribeiro, Leonardo Arcuri, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 7607.

https://doi.org/10.1182/blood-2025-7607

Published: 2025

Journal Articles

Molecular risk stratification of myelodysplastic syndromes in Brazil: A cohort applying IPSS-m and taxonomic classification

Frederico Honorato, Elvira Velloso, Paulo Campregher, Juliana Rocha, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Amanda Inacio Dias dos Santos, Rodrigo Kojima, Barbara Galvão, Nelson Hamerschlak, Fabio Santos

Blood (2025) 146 (Supplement 1): 7372.

https://doi.org/10.1182/blood-2025-7372

Published: 2025

Journal Articles

Peripheral blood or bone marrow grafts for unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis

Leonardo Arcuri, Victor Natal, Mariana Kerbauy, Guilherme Perini, Andreza Ribeiro, Nelson Hamerschlak, Carla Ribeiro

Blood (2025) 146 (Supplement 1): 6002.

https://doi.org/10.1182/blood-2025-6002

Published: 2025

Journal Articles

Outcomes of HLA-matched unrelated versus haploidentical hematopoietic cell transplantation in acute leukemia: A multicenter observational study in Brazil facilitated by the CIBMTR

Blood (2025) 146 (Supplement 1): 5981.

https://doi.org/10.1182/blood-2025-5981

Published: 2025

Journal Articles

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for hematopoietic cell transplantation in patients aged 60 years or older: A prospective study

Leonardo Arcuri, Mariana Kerbauy, Lucila Kerbauy, Juliana Rocha, Carolina Marques, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Ana de Rezende, Eduardo Weltman, Andreza Ribeiro, Marcos de Lima, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 2439.

https://doi.org/10.1182/blood-2025-2439

Published: 2025

Journal Articles

HLA and non-HLA factors in haploidentical donor selection: Insights from a brazilian single-center study

Newton Centurião, Leonardo Arcuri, Cinthya Da Silva, Mariana Kerbauy, Margareth Torres, João Guerra, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 2435.

https://doi.org/10.1182/blood-2025-2435

Published: 2025

Journal Articles

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: A prospective study

Leonardo Arcuri, Mariana Kerbauy, Lucila Kerbauy, Juliana Rocha, Carolina Marques, Tarcila Datoguia, Jade Zezzi Martins do Nascimento, Ana de Rezende, Eduardo Weltman, Roberto Sakuraba, Andreza Ribeiro, Marcos de Lima, Nelson Hamerschlak

Blood (2025) 146 (Supplement 1): 7738.

https://doi.org/10.1182/blood-2025-7738

Published: 2025

Journal Articles

Balancing efficacy and safety: IL-15 BCMA CAR-T cells vs. 2nd generation CAR-T in preclinical myeloma model

Jamile Ramos, Cleyson Barros, Thiago Mitsugi, Lays Trajano, Erica Vidal, Ingrid Souza, Robledo Ferreira, Yasmin Mamirato, Barbara Dos Reis, Julia Azevedo, Raquel M A Paiva, Oswaldo Okamoto, Larissa Cardoso, Nelson Hamerschlak, Lucila Kerbauy

Blood (2025) 146 (Supplement 1): 7635.

https://doi.org/10.1182/blood-2025-7635

Published: 2025

Journal Articles

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Blood (2025) 146 (Supplement 1): 3673.

https://doi.org/10.1182/blood-2025-3673

Published: 2025

Journal Articles

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

Blood (2025) 146 (Supplement 1): 2524.

https://doi.org/10.1182/blood-2025-2524

Published: 2025

Journal Articles

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Blood (2025) 146 (Supplement 1): 5391.

https://doi.org/10.1182/blood-2025-5391

Published: 2025

Journal Articles

Machine learning ensemble models for genetic-based classification of myeloproliferative and myelodysplastic/myeloproliferative neoplasms: Comparing a multinomial vs binomial approach

Jade Zezzi Martins do Nascimento, Amanda Inácio Dias Ennes, Mariana Lorenzi Savioli, Tarcila Datoguia, Aline Nishimoto, Carolina Marques, André Américo, Luiz Gustavo Cortes, Leonardo Javier Arcuri, Paulo Campregher, Nelson Hamerschlak, Fabio Santos

Blood (2025) 146 (Supplement 1): 7868.

https://doi.org/10.1182/blood-2025-7868

Published: 2025

Journal Articles

Manufacturing variability of CAR-T cells in patients with B-cell lymphoma: Findings from the carthiae-1 clinical trial

Raquel Paiva, Julia Teixeira Cottas de Azevedo, João Agostinho Machado-Neto, Denise Oliveira, Juliana Godoy, Keli Lima, Heitor Andrade, Mariana Velloso, Fernanda Assir, Isabel Bello, Oswaldo Okamoto, Mariana Kerbauy, Jose Kutner, Nelson Hamerschlak, Lucila Kerbauy

Blood (2025) 146 (Supplement 1): 7701.

https://doi.org/10.1182/blood-2025-7701

Published: 2025

Journal Articles

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Blood (2025) 146 (Supplement 1): 1854.

https://doi.org/10.1182/blood-2025-1854

Published: 2025

Journal Articles

Healthcare inequities in Latin America outweigh the benefits of pediatric regimens in adult acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 288.

https://doi.org/10.1182/blood-2025-288

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Implementation of a next generation sequencing painel for lymphoid malignancies in Brazil: First report of molecular features in a low-middle income country

Uncovering the genomic landscape of DLBCL in Latin America: First report of two centers from Brazil and Chile

Germline predisposition in hematologic malignancies: A study of 22 cases with germline DNA

The brazilian registry of hematopoietic cell transplantation and cellular therapy: A MODEL of collaborative progress and DATA management leadership

DATA structuring and performance indicators for decision making in oncology and hematology

Real-world outcomes of teclistamab in triple-exposed relapsed/refractory multiple myeloma: Brazilian single-center experience

Molecular risk stratification of myelodysplastic syndromes in Brazil: A cohort applying IPSS-m and taxonomic classification

Peripheral blood or bone marrow grafts for unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis

Outcomes of HLA-matched unrelated versus haploidentical hematopoietic cell transplantation in acute leukemia: A multicenter observational study in Brazil facilitated by the CIBMTR

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for hematopoietic cell transplantation in patients aged 60 years or older: A prospective study

HLA and non-HLA factors in haploidentical donor selection: Insights from a brazilian single-center study

Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: A prospective study

Balancing efficacy and safety: IL-15 BCMA CAR-T cells vs. 2nd generation CAR-T in preclinical myeloma model

Impact of high-dose methotrexate in both central nervous system relapse and systemic progression in high-risk DLBCL: A retrospective analysis of a brazilian cohort

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

Validation of baseline total metabolic tumor volume (TMTV) as a predictor of early progression (POD24) in follicular lymphoma: A retrospective study of 100 patients in Brazil.

Machine learning ensemble models for genetic-based classification of myeloproliferative and myelodysplastic/myeloproliferative neoplasms: Comparing a multinomial vs binomial approach

Manufacturing variability of CAR-T cells in patients with B-cell lymphoma: Findings from the carthiae-1 clinical trial

Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4

Healthcare inequities in Latin America outweigh the benefits of pediatric regimens in adult acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only